Antituberculosis treatment: Increasing evidence for drug effects on innate cellular immunity

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 4, 2001, Pages 686-689

  Tiemessen, C T ^a   Shalekoff, S ^a   Meddows Taylor, S ^a   Martin, D J ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; G PROTEIN COUPLED RECEPTOR; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

CELL MIGRATION; CELLULAR IMMUNITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; NEUTROPHIL; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST;

FORECASTING; GTP-BINDING PROTEINS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; NEUTROPHILS; RECEPTORS, CELL SURFACE; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 0034964323     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.4.686-689.2001     Document Type: Note

References (23)

1. Evaluation of phagocyte functions, inflammatory lymphokine activities and in vitro antibody synthesis in patients with active and chronic pulmonary tuberculosis
2. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
3. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
4. The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor
5. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
6. The chemotactic receptor for human C5a anaphylatoxin
7. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
8. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
9. Structure and functional expression of a human interleukin-8 receptor
10. Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans
11. Impaired interleukin-8-induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1-infected individuals
12. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis
13. Altered expression of CD88 and associated impairment of complement C5a-induced neutrophil responses in human immunodeficiency virus type 1-infected patients with and without pulmonary tuberculosis
14. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils
15. Cloning of complementary DNA encoding a functional human interleukin-8 receptor
16. Immunoprofile studies in patients with pulmonary tuberculosis. IV. Tuberculin skin reaction and test of inhibition of blood leukcoyte migration
17. Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program
18. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils
19. Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection
20. Impairment of neutrophil function in HIV-1 infection and pulmonary tuberculosis
21. Influence of tuberculosis on human immunodeficiency virus (HIV-1): Enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis
22. Accelerated course of human immunodeficiency virus infection after tuberculosis
23. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: A randomised controlled trial